Bioverge

Fusing sci-fi with fintech through a health + tech investment platform
Overview
Raised: $138,007
Rolling Commitments ($USD)
08/31/2023
$1,586
251
2017
Financial & Insurance Products & Services
Fintech
B2B/B2C
High
Low
Summary Profit and Loss Statement
FY 2022 | FY 2021 | |
---|---|---|
Revenue |
$247,786 |
$251,720 |
COGS |
$49,972 |
$26,101 |
Tax |
$0 |
$0 |
| ||
| ||
Net Income |
$-406,203 |
$-591,903 |
Summary Balance Sheet
FY 2022 | FY 2021 | |
---|---|---|
Cash |
$324,314 |
$487,668 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$567,769 |
$751,759 |
Short-Term Debt |
$52,668 |
$178,120 |
Long-Term Debt |
$0 |
$0 |
Total Liabilities |
$52,668 |
$178,120 |
Raise History
Offering Name | Close Date | Platform | Valuation/Cap | Total Raised | Security Type | Status | Reg Type |
---|---|---|---|---|---|---|---|
Bioverge | 08/07/2023 | Republic | $25,000,000 | $138,007 | SAFE | Funded | RegCF |
Bioverge | 02/28/2022 | Netcapital | $10,014,900 | $710,266 | Equity - Common | Funded | RegCF |
Bioverge | 05/13/2021 | Netcapital | $10,014,900 | $0 | Equity - Common | Funded | Test the Waters / RegCF |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual